Cara Nelson

474 total citations
32 papers, 314 citations indexed

About

Cara Nelson is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Cara Nelson has authored 32 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Cara Nelson's work include Chronic Lymphocytic Leukemia Research (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Cara Nelson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Cara Nelson collaborates with scholars based in United States, Czechia and United Kingdom. Cara Nelson's co-authors include Nina Isoherranen, Heidi J. Wengreen, Chris D. Corcoran, Ron Munger, Florence Namour, Chantal Tasset, Jing Jing, Yoshiyuki Shirasaka, John K. Amory and Jisun Paik and has published in prestigious journals such as Blood, Gastroenterology and Cancer Research.

In The Last Decade

Cara Nelson

31 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cara Nelson United States	8	117	59	58	48	35	32	314
Meng Hua Tao United States	14	192 1.6×	38 0.6×	123 2.1×	94 2.0×	30 0.9×	17	446
Karunakaran Coral India	17	192 1.6×	51 0.9×	15 0.3×	64 1.3×	21 0.6×	28	504
Jingjing Zhao China	9	85 0.7×	36 0.6×	13 0.2×	37 0.8×	34 1.0×	29	246
Joe Carroll Ireland	10	235 2.0×	26 0.4×	30 0.5×	59 1.2×	27 0.8×	23	458
Jinxian Pu China	15	248 2.1×	22 0.4×	25 0.4×	60 1.3×	48 1.4×	55	512
Tomozumi Takatani Japan	13	238 2.0×	47 0.8×	115 2.0×	95 2.0×	52 1.5×	48	525
Mary Anne Preece United Kingdom	11	162 1.4×	66 1.1×	46 0.8×	33 0.7×	24 0.7×	20	377
Xiaohong Xue China	10	140 1.2×	23 0.4×	21 0.4×	67 1.4×	40 1.1×	24	350
Jeremy S. Haley United States	9	110 0.9×	110 1.9×	17 0.3×	65 1.4×	30 0.9×	21	402
Patrizia Pattini Italy	11	337 2.9×	57 1.0×	60 1.0×	43 0.9×	41 1.2×	24	523

Countries citing papers authored by Cara Nelson

Since Specialization

Citations

This map shows the geographic impact of Cara Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara Nelson more than expected).

Fields of papers citing papers by Cara Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara Nelson. The network helps show where Cara Nelson may publish in the future.

Co-authorship network of co-authors of Cara Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Cara Nelson. A scholar is included among the top collaborators of Cara Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cara Nelson. Cara Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nelson, Cara, et al.. (2025). 307-OR: Effect of Oral Small Molecule GLP-1 Receptor Agonist TERN-601 in Healthy Participants with Obesity or Overweight—A First-in-Human Study. Diabetes. 74(Supplement_1). 1 indexed citations

Younis, Islam R., Cara Nelson, Elijah J. Weber, et al.. (2024). Pharmacokinetics and Safety of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment. The Journal of Clinical Pharmacology. 64(7). 878–886. 2 indexed citations

Weber, Elijah J., Islam R. Younis, Cara Nelson, et al.. (2024). Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug–Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase. Clinical Pharmacokinetics. 63(10). 1423–1434. 3 indexed citations

Younis, Islam R., Cara Nelson, Brian J. Kirby, et al.. (2023). Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist. Clinical Pharmacokinetics. 62(4). 609–621. 2 indexed citations

Younis, Islam R., Chia‐Hsiang Hsueh, Cara Nelson, et al.. (2023). Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist. The Journal of Clinical Pharmacology. 63(9). 1017–1025. 1 indexed citations

Younis, Islam R., Cara Nelson, Dora Ding, et al.. (2023). Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist. The Journal of Clinical Pharmacology. 63(5). 560–568. 4 indexed citations

Namour, Florence, et al.. (2022). Filgotinib: A Clinical Pharmacology Review. Clinical Pharmacokinetics. 61(6). 819–832. 36 indexed citations

Nelson, Cara, et al.. (2021). Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants. Clinical Pharmacology in Drug Development. 11(2). 235–245. 14 indexed citations

Nelson, Cara, et al.. (2020). Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects. Clinical Pharmacokinetics. 59(9). 1109–1117. 13 indexed citations

10.

Meng, Amy, Cara Nelson, Brian J. Kirby, et al.. (2020). SAT0149 EXPOSURE-RESPONSE RELATIONSHIPS FOR EFFICACY AND SAFETY OF FILGOTINIB AND ITS METABOLITE GS-829845 IN SUBJECTS WITH RHEUMATOID ARTHRITIS BASED ON PHASE 2 AND PHASE 3 STUDIES. Annals of the Rheumatic Diseases. 79. 1013–1014. 1 indexed citations

11.

Jürgensmeier, Juliane M., Hoa Truong, Lianqing Zheng, et al.. (2017). Abstract 4082: Time- and exposure-dependent pharmacodynamic changes induced by the BTK inhibitor GS-4059 in healthy subjects. Cancer Research. 77(13_Supplement). 4082–4082. 1 indexed citations

12.

Jing, Jing, Cara Nelson, Jisun Paik, et al.. (2017). Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions. Journal of Pharmacology and Experimental Therapeutics. 361(2). 246–258. 34 indexed citations

13.

Nelson, Cara, Brian J. Kirby, Nhin Lu, et al.. (2017). Evaluation of cytochrome P450- and transporter-mediated drug-drug interactions with the farnesoid x receptor agonist GS-9674 and phenotypic probe substrates and inhibitors/inducers. Journal of Hepatology. 66(1). S151–S151. 2 indexed citations

14.

Salles, Gilles, Franck Morschhauser, Bruce D. Cheson, et al.. (2016). Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of GS-4059 in Combination with Idelalisib in Subjects with B-Cell Malignancies. Blood. 128(22). 2961–2961. 1 indexed citations

15.

Nelson, Cara, et al.. (2013). Therapeutic Potential of the Inhibition of the Retinoic Acid Hydroxylases CYP26A1 and CYP26B1 by Xenobiotics. Current Topics in Medicinal Chemistry. 13(12). 1402–1428. 64 indexed citations

16.

Wen, Jiadi, Fátima Lopes, Gabriela Soares, et al.. (2013). Phenotypic and functional consequences of haploinsufficiency of genes from exocyst and retinoic acid pathway due to a recurrent microdeletion of 2p13.2. Orphanet Journal of Rare Diseases. 8(1). 100–100. 21 indexed citations

17.

Pouliot, Wendy A., Meir Bialer, Tawfeeq Shekh‐Ahmad, et al.. (2012). A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus. Neuroscience. 231. 145–156. 29 indexed citations

18.

Wengreen, Heidi J., Cara Nelson, Ronald G. Munger, & Chris Corcoran. (2010). Prospective study of ready-to-eat breakfast cereal consumption and cognitive decline among elderly men and women. The journal of nutrition health & aging. 15(3). 202–207. 5 indexed citations

19.

Nelson, Cara, Larryn W. Peterson, Chester J. Provoda, et al.. (2009). Puromycin-sensitive aminopeptidase: An antiviral prodrug activating enzyme. Antiviral Research. 85(3). 482–489. 7 indexed citations

20.

Nelson, Cara, Heidi J. Wengreen, Ron Munger, & Chris D. Corcoran. (2009). Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: The cache county memory, health, and aging study. The journal of nutrition health & aging. 13(10). 899–905. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact